Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation.
Chen
J W C
JW
Liver and Hepatobiliary Unit, The Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Edgbaston B15 2TL, Birmingham, UK.
Pehlivan
M
M
Gunson
B K
BK
Buckels
J A
JA
McMaster
P
P
Mayer
D
D
D002423:Cause of Death; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus